Organon Korea
As an Organon Founder, you join a company with purpose at the center of everything we do.
We are dedicated to making a world of difference in everyday health, and to becoming the leading women's health care company.
We look forward to your contributions to our vision, mission and values.
We are dedicated to making a world of difference in everyday health, and to becoming the leading women's health care company.
We look forward to your contributions to our vision, mission and values.
Satellite Symposium
The Benefit of Atorvastatin/Ezetimine Combination Therapy in Coronary Risk Patients
Organized by CVRF and Supported by Educational Grant from Organon Korea
Thursday, April 22
1:00 PM ~ 1:52 PM * Korea Standard Time (UTC/GMT +9:00)
Live Theater (Channel 2)
Moderator(s): Seung-Ho Hur, Myung-Ho Jeong
Panelist(s): Gyung-Min Park, Suk Min Seo
| 1:00 PM | Opening Remarks Speaker: Myung-Ho Jeong |
| 1:05 PM | Is Combination Therapy Recommended for All High Risk Patients : When and Why Combination Therapy Is Needed?  Lecturer: Hyuck Jun Yoon |
| 1:20 PM | Discussion |
| 1:30 PM | The Benefit of High Intensity Atorvastatin/Ezetimine Combination Therapy in Coronary Risk Patients with Hypercholesterolemia Lecturer: Young-Hoon Jeong |
| 1:45 PM | Discussion |
| 1:50 PM | Closing Remarks Speaker: Myung-Ho Jeong |